AMENDED AND RESTATED ARVINAS IP CONTRIBUTION AGREEMENTArvinas Ip Contribution Agreement • February 23rd, 2023 • Arvinas, Inc. • Pharmaceutical preparations • Delaware
This AMENDED AND RESTATED ARVINAS IP CONTRIBUTION AGREEMENT (this “Agreement”) is entered into as of December 20, 2022 (the “Effective Date”) by and between Oerth Bio LLC, f/k/a Protag LLC, a limited liability company organized under the laws of Delaware (“Oerth”), and Arvinas Operations, Inc., a corporation organized under the laws of Delaware (“Arvinas”). Oerth and Arvinas are sometimes referred to herein individually as a “Party” and collectively as the “Parties.”
Amendment No. 3 to Agreement (“Amendment No. 3”)Agreement • February 23rd, 2023 • Arvinas, Inc. • Pharmaceutical preparations
Name of Original Agreement: Research Collaboration and License Agreement (the “Original Agreement,” and together with previous amendments, if any, as described below, the “Agreement”)
